Goldman Sachs Reiterates Neutral on Amarin Ahead of Advisory Panel

Loading...
Loading...
In a report published Wednesday, Goldman Sachs analyst Gary Nachman reiterated a Neutral rating and $6.80 price target on
Amarin Corporation plcAMRN
. In the report, Goldman Sachs noted, “Given that the upcoming advisory panel for AMRN's Vascepa in the expanded ANCHOR indication on Oct. 16 is such an important catalyst (followed by the PDUFA on Dec. 20), we wanted to try and frame the potential outcomes and what we think it could mean to the stock, as well as provide an options strategy. We continue to believe there is a greater than 50% chance for a favorable outcome (we estimate ~60%). However, we view the overall risk/reward in the stock going into this event as being less favorable given reasonably high expectations. We remain Neutral.” Amarin Corporation plc closed on Tuesday at $6.69.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorReiterationAnalyst RatingsGary NachmanGoldman Sachs
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...